TTX logo

Tetratherix Limited Stock Price

ASX:TTX Community·AU$323.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

TTX Share Price Performance

AU$0
-4.12 (-100.00%)
AU$0
-4.12 (-100.00%)
Price AU$0

TTX Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with limited growth.

2 Risks
1 Reward

Tetratherix Limited Key Details

AU$4.7m

Revenue

AU$0

Cost of Revenue

AU$4.7m

Gross Profit

AU$14.0m

Other Expenses

-AU$9.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.18
100.00%
-200.12%
5.8%
View Full Analysis

About TTX

Founded
2015
Employees
15
CEO
William Knox
WebsiteView website
tetratherix.com

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing, tissue regeneration, and precision medicine applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.

Recent TTX News & Updates

Recent updates

No updates